{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:03:11Z","timestamp":1790402591788,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.1093\/cvr\/cvu026","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T21:35:17Z","timestamp":1391636117000},"page":"138-147","source":"Crossref","is-referenced-by-count":103,"title":["Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition"],"prefix":"10.1093","volume":"102","author":[{"given":"Mariarosaria","family":"Bucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vellecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brancaleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calderone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Papapetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"key\n\t\t\t\t20170523004111_CVU026C1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170523004111_CVU026C2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1015709617405","article-title":"Pathophysiologic and therapeutic importance of tissue ACE: a consensus report","volume":"16","author":"Dzau","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t20170523004111_CVU026C3","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/01.CIR.86.5.1566","article-title":"Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure","volume":"86","author":"Hirsch","year":"1992","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523004111_CVU026C4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1875-9114.1998.tb03121.x","article-title":"Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors","volume":"18","author":"White","year":"1998","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170523004111_CVU026C5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FJC.0b013e318280e16e","article-title":"Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in renin-angiotensin system","volume":"61","author":"Chaudhary","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(94)92811-8","article-title":"Gissi-3","volume":"344","author":"Julian","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170523004111_CVU026C7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.1999.tb00008.x","article-title":"Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar cardioprotective properties","volume":"17","author":"Subissi","year":"1999","journal-title":"Cardiovasc Drug Rev"},{"key":"key\n\t\t\t\t20170523004111_CVU026C8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170523004111_CVU026C9","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjp.0703498","article-title":"Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure","volume":"130","author":"Buikema","year":"2000","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjhyper.2006.09.020","article-title":"Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients","volume":"20","author":"Pasini","year":"2007","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170523004111_CVU026C11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1991.tb05549.x","article-title":"Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?","volume":"31","author":"McMurray","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/147323000503300103","article-title":"Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril","volume":"33","author":"Evangelista","year":"2005","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t20170523004111_CVU026C13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/00005344-198409000-00021","article-title":"Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats","volume":"6","author":"Unger","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(25)32897-1","article-title":"Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421","volume":"220","author":"Cohen","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523004111_CVU026C15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.HYP.22.2.139","article-title":"Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril","volume":"22","author":"Wu","year":"1993","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523004111_CVU026C16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1172\/JCI119419","article-title":"The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice","volume":"99","author":"Esther","year":"1997","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170523004111_CVU026C17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bmc.2003.10.054","article-title":"11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat","volume":"12","author":"Matarrese","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170523004111_CVU026C18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bjp.2008.296","article-title":"Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice","volume":"155","author":"Brancaleone","year":"2008","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.110.176016","article-title":"Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed","volume":"337","author":"d'Emmanuele di Villa Bianca","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523004111_CVU026C20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev.nutr.24.012003.132418","article-title":"Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine","volume":"24","author":"Stipanuk","year":"2004","journal-title":"Annu Rev Nutr"},{"key":"key\n\t\t\t\t20170523004111_CVU026C21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/MN:26:1:013","article-title":"Hydrogen sulfide as a neuromodulator","volume":"26","author":"Kimura","year":"2002","journal-title":"Mol Neurobiol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrurol.2011.45","article-title":"Hydrogen sulfide and erectile function: a novel therapeutic target","volume":"8","author":"d'Emmanuele di Villa Bianca","year":"2011","journal-title":"Nat Rev Urol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C23","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","article-title":"Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity","volume":"30","author":"Bucci","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C24","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170523004111_CVU026C25","doi-asserted-by":"crossref","first-page":"e53319","DOI":"10.1371\/journal.pone.0053319","article-title":"cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation","volume":"7","author":"Bucci","year":"2012","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170523004111_CVU026C26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1162667","article-title":"H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase","volume":"322","author":"Yang","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20170523004111_CVU026C27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj2060267","article-title":"Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat","volume":"206","author":"Stipanuk","year":"1982","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20170523004111_CVU026C28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2008.05.014","article-title":"Hydrogen sulphide is involved in testosterone vascular effect","volume":"56","author":"Bucci","year":"2009","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C29","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.bmc.2012.02.028","article-title":"Thioglycine and l-thiovaline: biologically active H(2)S-donors","volume":"20","author":"Zhou","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170523004111_CVU026C30","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523004111_CVU026C31","first-page":"102","article-title":"Endogenous H2S is involved in the development of spontaneous hypertension","volume":"35","author":"Du","year":"2003","journal-title":"Beijing Da Xue Xue Bao"},{"key":"key\n\t\t\t\t20170523004111_CVU026C32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2003.11.081","article-title":"The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats","volume":"313","author":"Yan","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170523004111_CVU026C33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of atherosclerosis with ramipril","volume":"36","author":"MacMahon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C34","first-page":"591","article-title":"Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvasratin\/Enalapril Coronary Atherosclerosis Trial (SCAT)","volume":"13","author":"Teo","year":"1997","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.vph.2005.01.009","article-title":"Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins","volume":"42","author":"Asselbergs","year":"2005","journal-title":"Vasc Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ahj.2008.09.006","article-title":"Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide\/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension","volume":"156","author":"Napoli","year":"2008","journal-title":"Am Heart J"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170523004111_CVU026C37","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1111\/j.1365-2125.1989.tb03587.x","article-title":"Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE)","volume":"28","author":"Cushman","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170523004111_CVU026C38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/db07-1212","article-title":"ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes","volume":"57","author":"Tikellis","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170523004111_CVU026C39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ajh\/2.4.294","article-title":"Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs","volume":"2","author":"Cushman","year":"1989","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20170523004111_CVU026C40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.CIR.95.5.1115","article-title":"Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans","volume":"95","author":"Hornig","year":"1997","journal-title":"Circulation"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/102\/1\/138\/17393670\/cvu026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:52:03Z","timestamp":1746114723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1093\/cvr\/cvu026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,2,5]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvu026","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}